Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.)
Vision Marine Technologies Inc. (NASDAQ:VMAR) ("Vision Marine" or the "Company"), a global leader and innovator within the performance electric recreational boating industry, today announced that it has entered into
NIO Inc. (NYSE:NIO, HKEX: 9866, SGX: NIO)))) ("NIO" or the "Company"), a pioneer and a leading company in the premium smart electric vehicle market, today announced a proposed offering (the "Notes Offering") of US$500
EQT Corporation (NYSE:EQT) ("EQT" or the "Company") today announced it has entered into a Heads of Agreement (HOA) for liquefaction services from Commonwealth LNG's facility in Cameron, Louisiana to
United States Steel Corporation (NYSE:X) today provided third quarter 2023 adjusted net earnings per diluted share guidance of $1.10 to $1.15. Third quarter 2023 adjusted EBITDA is expected to be approximately $550
HEI Chief Financial Officer Paul Ito to Become CFO of Hawaiian Electric Company Through Approximately December 31, 2024, Following Planned Retirement of Tayne SekimuraUtility Industry Veteran Scott DeGhetto to Join HEI